» Articles » PMID: 32092072

Antifungal Susceptibility of Candida Species to Copper Oxide Nanoparticles on Polycaprolactone Fibers (PCL-CuONPs)

Overview
Journal PLoS One
Date 2020 Feb 25
PMID 32092072
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The integration of metallic or ceramic nanoparticles in polymer matrices has improved the antimicrobial and antifungal behavior, resulting in the search for composites with increased bactericidal and antimycotic properties. A polycaprolactone fibers with copper oxide nanoparticles was prepared. Polycaprolactone-copper fibers (PCL- CuONPs) were prepared into two major steps in situ method: (a) Synthesis of CuO particles, then (b) incorporation of polycaprolactone to electrospun process. The first step is the reduction of Cu+2 ions by gallic acid in N,N-dimethylformamide and tetrahydrofuran solution with the simple addition of polycaprolactone in the solution for the second electrospun step. Raman spectra provide information about the nature of the copper oxide synthesized. There are three Raman peaks in the sample, at 294 and 581 cm-1 and a very broad band from 400 to 600 cm-1 which are characteristics bands for CuO. Scanning electron microscopy (TEM) revealed copper oxide nanoparticles with semispherical shapes with diameter 35 ±11 nm. Dynamic light scattering (DLS) analysis showed uniform CuONPs in a range of 88±11 nm. Scanning electron microscopy (SEM) of PCL-CuONps reveled fibers with diameters ranging from 925 to 1080 nm were successfully obtained by electrospinning technique. Orientation, morphology and diameter were influenced by the increment on CuONPs concentration, with the smaller diameter present in samples prepared from low concentrated solutions. The antimycotic applicability of the composite was evaluated to determine the antifungal activity in three species of the genus Candida (Candida albicans, Candida glabrata and Candida tropicalis). PCL-CuONPs exhibit a considerable antifungal effect on all species tested. The preparation of PCL-CuONPs was simple, fast and low-cost for practical application as an antifungal dressing.

Citing Articles

Enhanced anti- efficacy of Des Moul mediated copper nanoparticles against clinically isolated .

Bala R, Kaur N, Gupta N, Aman S, Shriwastav S Curr Med Mycol. 2024; 9(4):24-32.

PMID: 38983616 PMC: 11230144. DOI: 10.22034/cmm.2024.345176.1493.


Is Silver Addition to Scaffolds Based on Polycaprolactone Blended with Calcium Phosphates Able to Inhibit and Adhesion and Biofilm Formation?.

Menotti F, Scutera S, Maniscalco E, Coppola B, Bondi A, Costa C Int J Mol Sci. 2024; 25(5).

PMID: 38474027 PMC: 10931636. DOI: 10.3390/ijms25052784.


Antifungal activity of FeO@SiO/Schiff-base/Cu(II) magnetic nanoparticles against pathogenic Candida species.

Azadi S, Azizipour E, Amani A, Vaez A, Zareshahrabadi Z, Abbaspour A Sci Rep. 2024; 14(1):5855.

PMID: 38467729 PMC: 10928175. DOI: 10.1038/s41598-024-56512-5.


Development and characterization of biogenic copper oxide nanoparticles, with an exploration of their antibacterial and antioxidant potential.

Tyagi S, Kumar A, Tyagi P, Hatami M 3 Biotech. 2023; 14(1):20.

PMID: 38144392 PMC: 10733263. DOI: 10.1007/s13205-023-03869-5.


The Antimicrobial Applications of Nanoparticles in Veterinary Medicine: A Comprehensive Review.

Rodrigues M, Pinto P, Dias R, Biscoto G, Salvato L, Millan R Antibiotics (Basel). 2023; 12(6).

PMID: 37370277 PMC: 10295505. DOI: 10.3390/antibiotics12060958.


References
1.
Nordin M, Wan Harun W, Abdul Razak F . Antifungal susceptibility and growth inhibitory response of oral Candida species to Brucea javanica Linn. extract. BMC Complement Altern Med. 2013; 13:342. PMC: 3898397. DOI: 10.1186/1472-6882-13-342. View

2.
Nelson P, Paetznick V, Rex J . Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991. J Clin Microbiol. 1999; 37(5):1625-7. PMC: 84856. DOI: 10.1128/JCM.37.5.1625-1627.1999. View

3.
Radakovic D, Reboredo J, Helm M, Weigel T, Schurlein S, Kupczyk E . A multilayered electrospun graft as vascular access for hemodialysis. PLoS One. 2017; 12(10):e0185916. PMC: 5638257. DOI: 10.1371/journal.pone.0185916. View

4.
Brunke S, Hube B . Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol. 2012; 15(5):701-8. PMC: 3654559. DOI: 10.1111/cmi.12091. View

5.
Munoz-Escobar A, Ruiz-Baltazar A, Reyes-Lopez S . Novel Route of Synthesis of PCL-CuONPs Composites With Antimicrobial Properties. Dose Response. 2019; 17(3):1559325819869502. PMC: 6699009. DOI: 10.1177/1559325819869502. View